Tabor Asset Management LP Has $9.30 Million Stake in Cinemark Holdings, Inc. (NYSE:CNK)


Tabor Asset Management LP Has $9.30 Million Stake in Cinemark Holdings, Inc. (NYSE:CNK)

Tabor Asset Management LP grew its position in Cinemark Holdings, Inc. (NYSE:CNK - Free Report) by 25.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 333,906 shares of the company's stock after acquiring an additional 68,237 shares during the quarter. Cinemark accounts for about 4.5% of Tabor Asset Management LP's holdings, making the stock its 6th largest position. Tabor Asset Management LP owned 0.27% of Cinemark worth $9,296,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CNK. Maverick Capital Ltd. lifted its position in shares of Cinemark by 1,356.4% in the 3rd quarter. Maverick Capital Ltd. now owns 1,517,771 shares of the company's stock worth $42,255,000 after acquiring an additional 1,413,557 shares during the period. BNP Paribas Financial Markets raised its holdings in shares of Cinemark by 1,532.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 650,227 shares of the company's stock worth $18,102,000 after buying an additional 610,398 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Cinemark in the 3rd quarter worth approximately $12,133,000. Hennessy Advisors Inc. raised its holdings in shares of Cinemark by 18.1% in the 2nd quarter. Hennessy Advisors Inc. now owns 1,530,200 shares of the company's stock worth $33,083,000 after buying an additional 234,400 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Cinemark by 5.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,914,708 shares of the company's stock worth $63,012,000 after buying an additional 148,076 shares in the last quarter.

In other news, insider Valmir Fernandes sold 25,000 shares of the firm's stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $32.68, for a total value of $817,000.00. Following the transaction, the insider now directly owns 179,729 shares in the company, valued at $5,873,543.72. This trade represents a 12.21 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.30% of the company's stock.

CNK stock opened at $35.43 on Friday. The stock has a market capitalization of $4.33 billion, a price-to-earnings ratio of 22.85, a P/E/G ratio of 1.78 and a beta of 2.38. The company has a debt-to-equity ratio of 3.46, a current ratio of 0.98 and a quick ratio of 0.96. The business has a fifty day moving average price of $30.54 and a 200 day moving average price of $25.67. Cinemark Holdings, Inc. has a fifty-two week low of $13.19 and a fifty-two week high of $36.28.

Cinemark (NYSE:CNK - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The company reported $1.19 EPS for the quarter, beating analysts' consensus estimates of $0.58 by $0.61. The firm had revenue of $921.80 million for the quarter, compared to analyst estimates of $894.90 million. Cinemark had a return on equity of 60.21% and a net margin of 8.36%. The business's quarterly revenue was up 5.4% compared to the same quarter last year. During the same period last year, the company earned $0.61 EPS. Analysts expect that Cinemark Holdings, Inc. will post 2 EPS for the current fiscal year.

CNK has been the subject of a number of recent research reports. Morgan Stanley increased their target price on Cinemark from $29.00 to $35.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. StockNews.com raised Cinemark from a "sell" rating to a "hold" rating in a report on Sunday, November 10th. Roth Mkm increased their target price on Cinemark from $30.00 to $33.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. Barrington Research raised Cinemark from a "market perform" rating to an "outperform" rating and set a $36.00 target price for the company in a report on Thursday, October 31st. Finally, Macquarie raised their price target on Cinemark from $32.00 to $34.00 and gave the company an "outperform" rating in a report on Friday, November 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Cinemark currently has an average rating of "Moderate Buy" and a consensus target price of $32.80.

View Our Latest Research Report on Cinemark

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Cinemark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.

While Cinemark currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Previous articleNext article

POPULAR CATEGORY

corporate

10581

tech

11464

entertainment

12996

research

5929

misc

13799

wellness

10505

athletics

13827